Akoya Biosciences has commercially released Codex, its tissue analysis and biomarker discovery system, and Phenoptics 2.0, its next-generation biomarker multiplexing platform. According to the firm, the new platforms provide scientists with a detailed solution for multiplexing immunofluorescence from discovery through clinical and translational research.
The Codex system includes a fluidics-based instrument, reagents, and a software analysis suite. Users can simultaneously analyze more than 40 protien markers for spatially resolved tissue characterization with single-cell resolution. The firm said that the system allows customers to design custom panels using a combination of Akoya-validated, ready-to-use antibodies and customer antibodies of interest.
According to Akoya, Phenoptics 2.0 uses the Vetra Polaris imaging system, Opal detection reagents, and inForm analysis software. With the release, the firm is introducing its Motif technology, which simultaneously collects multispectral images on whole-slide tissue sections of up to seven colors. Phenoptics 2.0 also includes multispectral analysis of up to nine colors in regions of interest for deeper interrogation of tissue samples.